Skip to main content

Table 1 Results of base case NMA: Difference in intervention versus the comparator for CFB in trough FEV 1 (mL) at 6 months, 95% credible intervals, and probability that the intervention is better than the comparator

From: Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis

Intervention

Comparator

PLACEBO

TIO 18

SAL 50

FOR 12

TIO 5

IND 150

IND 300

GPM 50

PLACEBO

estimate

0

−115

−80

−60

−111

−152

−160

−133

95% CrI

  

−132

−100

−99

−62

−105

−14

−140

−85

−179

−126

−187

−133

−165

−102

P(better)

  

<1%

<1%

1%

<1%

<1%

<1%

<1%

TIO 18

estimate

115

0

35

55

3

−37

−44

−18

95% CrI

100

132

  

12

58

8

104

−29

36

−66

−8

−74

−14

−51

16

P(better)

>99%

  

>99%

99%

59%

1%

<1%

14%

SAL 50

estimate

80

−35

0

21

−31

−72

−79

−53

95% CrI

62

99

−58

−12

  

−28

70

−65

2

−102

−42

−111

−47

−89

−17

P(better)

>99%

0%

  

81%

3%

<1%

<1%

<1%

FOR 12

estimate

60

−55

−21

0

−52

−93

−100

−73

95% CrI

14

105

−104

−8

−70

28

  

−106

1

−143

−42

−145

−54

−129

−18

P(better)

99%

1%

19%

  

3%

<1%

<1%

1%

TIO 5

estimate

111

−3

31

52

0

−41

−48

−21

95% CrI

85

140

−36

29

−2

65

−1

106

  

−79

−2

−86

−9

−63

21

P(better)

>99%

41%

97%

97%

  

2%

1%

15%

IND 150

estimate

152

37

72

93

41

0

−7

19

95% CrI

126

179

8

66

42

102

42

143

2

79

  

−39

25

−21

60

P(better)

>99%

99%

>99%

>99%

98%

  

32%

83%

IND 300

estimate

160

44

79

100

48

7

0

27

95% CrI

133

187

14

74

47

111

54

145

9

86

−25

39

  

−15

67

P(better)

>99%

>99%

>99%

>99%

99%

68%

  

90%

GPM 50

estimate

133

18

53

73

21

−19

−27

0

95% CrI

102

165

−16

51

17

89

18

129

−21

63

−60

21

−67

15

  

P(better)

>99%

86%

>99%

99%

85%

17%

10%

  
  1. 95% CrI = 95% Credible Interval; P(better) = Probability of being the treatment being better than the comparator in terms of the outcome assessed; CFB = Change from baseline; FEV 1  = Forced expiratory volume; FOR 12 = Formoterol 12 μg twice daily (BID); GPM 50 = Glycopyrronium 50 μg once daily (OD); IND 150 = Indacaterol 150 μg OD; IND 300 = Indacaterol 300 μg OD; SAL 50 = Salmeterol 50 μg BID; TIO 5 = Tiotropium 5 μg OD; TIO 18 = Tiotropium 18 μg OD.